Immune Monitoring Workshop II

November 4, 2004
Fairmont Hotel
San Francisco, CA

An interactive workshop designed to take the proceedings of the highly successful 2001 Immune Monitoring Workshop to the next level. This program will focus on results with ex vivo assays generated within clinical studies, on development of novel refined assay systems exploiting functional cytometry to its limits, and on regulatory issues around immune monitoring in proof of concept studies, comparative phase II trials, and pivotal phase III trials. The confirmed faculty for this exceptional program consists of renowned specialists from academia, industry, the NCI, and the FDA whose goal is to publish guidelines for Immune Monitoring in a leading cancer journal in 2005. Further information regarding the Workshop is available in the iSBTc 2004 Preliminary Program, beginning on page 8.

Workshop Topics:
Funtional Cytometry
Assay Validation for Vaccine Potency Assessment
Montoring of Multi-Antigen Vaccines
Clinical Trials to Assess Vaccine Characteristics
Migration of Tumor-Specific T Cells
Tumor Escape Mechanisms: Clinical Observations
Panel Discussion

Workshop Program Committee:

Ulrich Keilholz, MD
Charité CBF
Berlin, Germany

Walter Urba, MD, PhD
Earle A. Chiles Research Institute
Portland, OR

Confirmed Faculty

Michael B. Atkins, MD
Beth Israel Deaconess Medical Center
Boston, MA

Mary L. Disis, MD
University of Washington
Seattle, WA

Steven Hirschfeld, MD, PhD
Rockville, MD

Patrick Hwu, MD
MD Anderson Cancer Center
Houston, TX

Michael T. Lotze, MD
University of Pittsburgh School of Medicine
Pittsburgh, PA

Vernon Maino, PhD
BD Biosciences
San Jose, CA

Francesco Marincola, MD
National Institutes of Health
Bethesda, MD

Pedro Romero, MD
Ludwig Institute
Lausanne, Switzerland

Carmen Scheibenbogen, MD
Charité CBF
Berlin, Germany

Craig L. Slingluff, Jr., MD
University of Virginia
Charlottesville, VA

Cassian Yee, MD
Fred Hutchinson Research Center
Seattle, WA

Jeffrey S. Weber, MD, PhD
USC Norris Cancer Center
Los Angeles, CA